Letters: Clover, Fauci Listeners respond to the interview with professor Joshua Clover from University of California, Davis, and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
NPR logo

Letters: Clover, Fauci

  • Download
  • <iframe src="https://www.npr.org/player/embed/113217396/113217759" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Letters: Clover, Fauci

Letters: Clover, Fauci

Letters: Clover, Fauci

  • Download
  • <iframe src="https://www.npr.org/player/embed/113217396/113217759" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Listeners respond to the interview with professor Joshua Clover from University of California, Davis, and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.

MADELEINE BRAND, host:

Time now for your mail and we have two corrections from Wednesdays program.

ROBERT SIEGEL, host:

I spoke with Senator Christopher Dodd, the chairman of the Senate Banking Committee about financial regulatory reform. And I said the Obama administration has proposed eliminating the Office of Thrift Supervision and keeping the Office of the Controller of the Currency in business. Well, actually the proposal calls for merging the two regulatory bodies into a new one, the National Bank Supervisor.

BRAND: In another piece on Wednesday about this weeks G-20 Summit, we mistakenly identified President Bushs chief aide at the G-20 meeting last December, we said Dan Prince. His name, in fact, is Dan Price.

Also this week, I spoke with Professor Joshua Clover from University of California, Davis, about the one day walk out he was planning at his school in response to recent budget cuts.

We got this note from Vivian-Lee Nyitray, the chair of the Religious Studies Department at the University of California, Riverside. She writes: The U.C. Davis faculty member who described massive class cancellations provided a misleading picture of the situation, at least on the Riverside campus. Many departments on our campus have signed resolutions of support for the walk out that included a pledge to meet classes as usual, but to devote time to discussion of the threat to public education by the erosion of public understanding and fiscal support.

SIEGEL: Yesterday, I spoke with Dr. Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases about a small success this week in the development of an HIV vaccine. I asked Dr. Fauci about the ethics of testing the vaccine and that caught the attention of Robert Blume(ph) in Cincinnati.

He writes this: As a participant in a two-year long HIV vaccine study which was completed more than five years ago, I can vouch that the researchers provided plenty of information regarding safer and less safe activities. He continues: Researchers dont have to hope that their study participants will not follow the counseling, they already know that despite their best efforts, many wont.

BRAND: We want to hear from you about our best efforts and when you think we fall in short. Send us a note, go to npr.org, click on Contact Us at the bottom of the page.

(Soundbite of music)

BRAND: This is NPR, National Public Radio.

Copyright © 2009 NPR. All rights reserved. Visit our website terms of use and permissions pages at www.npr.org for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.